"Lab based Ab tests can enable increased expanse of COVID-19 testing"- Arpan Malhotra

June 12, 2020 | Friday | Views

Arpan Malhotra, India Business Head - Diagnostics, Siemens Healthcare, Gurugram shares his thoughts on the ongoing COVID-19 situation

"Country is now moving towards a need for mass screening and community surveillance for COVID-19. Laboratory based antibody tests (CLIA) are not just higher in sensitivity, but are also scalable to very high throughputs. This can enable an increased expanse of COVID-19 testing to larger population via already available network of thousands of government and private facilities, that are equipped for this testing."

Arpan Malhotra, India Business Head - Diagnostics, Siemens Healthcare, Gurugram

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy